Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
01 December 2020 - 10:04PM
Edgar (US Regulatory)
Issuer Free Writing Prospectus
Dated November 30, 2020
|
Filed pursuant to Rule 433
Registration Statement No. 333-235991
Relating to Preliminary Prospectus Supplement
dated
November 30, 2020
|
Elanco Animal Health Incorporated
54,500,000 Shares
The following information
supplements the Preliminary Prospectus Supplement dated November 30, 2020, and is filed pursuant to Rule 433, under
Registration No. 333-235991. Terms used but not defined herein have the meanings ascribed to them in the Preliminary
Prospectus Supplement dated November 30, 2020.
Issuer:
|
|
Elanco Animal Health Incorporated
|
|
|
Ticker/Exchange:
|
|
ELAN/NYSE
|
|
|
Common Stock Offered by the Selling Shareholder:
|
|
54,500,000 shares
|
|
|
Option to Purchase Additional Shares:
|
|
8,175,000 shares
|
|
|
Public Offering Price:
|
|
$30.25 per share
|
We have been advised by the underwriters that, prior to purchasing
the shares of common stock being offered pursuant to the Preliminary Prospectus Supplement dated November 30, 2020, on November 30,
2020, one of the underwriters purchased on behalf of the syndicate, 152,909 shares of common stock at an average price of $30.498
per share in stabilizing transactions.
The issuer has filed a registration statement including
a prospectus and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest,
you should read the prospectus and prospectus supplement in that registration statement and other documents the issuer has filed
with the SEC for more complete information about the issuer and this offering. You may obtain these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, you may obtain a copy of the preliminary prospectus supplement
and the prospectus and, when available, the final prospectus supplement, from: BofA Securities, NC1-004-03-43, 200 North College
Street, 3rd floor, Charlotte, NC 28255-0001, Attention: Prospectus Department or by email at dg.prospectus_requests@bofa.com;
Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282-2198, by telephone at
1-866-471-2526, or by e-mail at prospectus-ny@ny.email.gs.com; or Credit Suisse Securities (USA) LLC, Attention: Prospectus
Department, 6933 Louis Stephens Drive, Morrisville, NC 27560, by telephone at 1-800-221-1037 or by email at usa.prospectus@credit-suisse.com.
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jul 2023 to Jul 2024